About CUV
CLINUVEL (CUV) is a pharmaceutical group focused on developing and commercialising treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders, as well as healthcare solutions for specialised populations. As pioneers in photo medicine and the family of melanocortin peptides
Find out what a historical investment in Clinuvel Pharmaceuticals would be worth today using our CUV stock calculator.
Market Capitalisation
$392.28M
Price-earnings ratio
12.05
Dividend yield
0.62%
High today
$8.14
Low today
$7.73
Open price
$8.05
52-week high
$13.48
52-week low
$7.73
Ready to start your investing journey with Stake?
Open an accountAnnouncements
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in CUV
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in CUV on Stake
- Buy CUV from A$3 brokerage
- Invest in 2,500+ Aussie stocks and ETFs
- CHESS-sponsored ASX trades
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
CUV related stocks